tiprankstipranks
Trending News
More News >
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market
Advertisement

Kairos Pharma, Ltd. (KAPA) Technical Analysis

Compare
117 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Kairos Pharma, Ltd.’s (KAPA) Moving Averages Convergence Divergence (MACD) indicator is 0.17, suggesting Kairos Pharma, Ltd. is a Buy.
Kairos Pharma, Ltd.’s (KAPA) 20-Day exponential moving average is 1.53, while Kairos Pharma, Ltd.’s (KAPA) share price is $1.61, making it a Buy.
Kairos Pharma, Ltd.’s (KAPA) 50-Day exponential moving average is 1.26, while Kairos Pharma, Ltd.’s (KAPA) share price is $1.61, making it a Buy.

Kairos Pharma, Ltd. (KAPA) Pivot Points

Sep 18, 2025, 06:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.37
1.42
1.52
1.57
1.67
1.72
1.82
Fibonacci
1.42
1.48
1.52
1.57
1.63
1.67
1.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kairos Pharma, Ltd. (KAPA) Moving Averages

Sep 18, 2025, 06:44 AM
Period
Simple
Exponential
MA5
1.69Sell
1.68Buy
MA10
1.74Sell
1.65Buy
MA20
1.49Buy
1.53Buy
MA50
1.18Buy
1.26Buy
MA100
0.91Buy
1.11Buy
MA200
1.11Buy
1.21Buy
Kairos Pharma, Ltd.’s (KAPA) 10-Day exponential moving average is 1.65, while Kairos Pharma, Ltd.’s (KAPA) share price is $1.61, making it a Buy.
Kairos Pharma, Ltd.’s (KAPA) 100-Day exponential moving average is 1.11, while Kairos Pharma, Ltd.’s (KAPA) share price is $1.61, making it a Buy.
Kairos Pharma, Ltd.’s (KAPA) stock price is $1.61 and Kairos Pharma, Ltd.’s (KAPA) 50-day simple moving average is 1.18, creating a Buy signal.
Kairos Pharma, Ltd.’s (KAPA) stock price is $1.61 and Kairos Pharma, Ltd.’s (KAPA) 100-day simple moving average is 0.91, creating a Buy signal.
Kairos Pharma, Ltd.’s (KAPA) stock price is $1.61 and Kairos Pharma, Ltd.’s (KAPA) 200-day simple moving average is 1.11, creating a Buy signal.

Kairos Pharma, Ltd. (KAPA) Technical Indicators

Sep 18, 2025, 06:44 AM
Name
Value
Implied Action
RSI (14)
61.88
Neutral
STOCH (9,6)
30.03
Neutral
STOCHRSI (14)
48.86
Neutral
MACD (12,26)
0.17
Buy
ADX (14)
47.00
Neutral
Williams %R
-47.25
Buy
CCI (14)
63.04
Neutral
ATR (14)
0.18
-
Ultimate Oscillator
55.26
Neutral
ROC
42.37
Buy
Kairos Pharma, Ltd.’s (KAPA) Relative Strength Index (RSI) is 61.88, creating a Neutral signal.
Kairos Pharma, Ltd.’s (KAPA) Trend Strength Indicator (ADX) is 47.00, creating a Neutral signal.
Kairos Pharma, Ltd.’s (KAPA) Commodity Channel Index (CCI) is 63.04, creating a Neutral signal.
Kairos Pharma, Ltd.’s (KAPA) Price Rate of Change (ROC) is 42.37, creating a Buy signal.

FAQ

Is KAPA a Buy, Hold, or Sell?
Based on KAPA’s technical indicators, KAPA is a Strong Buy.
    What is KAPA’s RSI (14)?
    KAPA’s RSI (14) is 61.88, which suggests KAPA is a Neutral.
      What is KAPA’s MACD?
      KAPA’s MACD is 0.17, which suggests KAPA is a Buy.
        What is KAPA’s 5-day moving average?
        KAPA’s 5-day moving average is 1.69, which suggests KAPA is a Sell.
          What is KAPA’s 20-day moving average?
          KAPA 20-day moving average is 1.49, which suggests KAPA is a Buy.
            What is KAPA’s 50-day moving average?
            KAPA’s 50-day moving average is 1.18, which suggests KAPA is a Buy.
              What is KAPA’s 200-day moving average?
              KAPA’s 200-day moving average is 1.11, which suggests KAPA is a Buy.
                What is KAPA’s Williams % R (14)?
                KAPA’s Williams % R (14) is -47.25, which suggests KAPA is a Buy.
                  What is KAPA’s CCI (14)?
                  KAPA’s CCI (14) is 63.04, which suggests KAPA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis